Nectar Lifescience Ltd

(NECLIFE)

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Share Price: ₹33.22 per share as on 06 Dec, 2024 04:01 PM
Market Capitalisation: ₹760.24Cr as of today
Revenue: ₹427.88Cr as on September 2024 (Q3 24)
Net Profit: ₹5.60Cr as on September 2024 (Q3 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal